This September is Pulmonary Fibrosis Awareness Month, which the Pulmonary Fibrosis Foundation (PFF) and allies have launched to educate the public about the disease family. Involving scarring of the lungs, pulmonary fibrosis gradually robs the breath from patients it affects. Some 250,000 Americans live with idiopathic pulmonary fibrosis, according to PFF. At present, two drugs…
Why Bioclinica tapped AI in immunotherapy trials early in the pandemic
An AI-based system proved its mettle in screening patients in immunotherapy trials, according to Dan Gebow, chief innovation officer at Bioclinica. Early in the COVID-19 pandemic, developers of cancer immunotherapies worried that the novel coronavirus would interfere with their clinical trial results. In previous years, the scientific community established that immunotherapy can rarely cause interstitial…